Document Detail


The coming of age of virus-like particle vaccines.
MedLine Citation:
PMID:  18953718     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Virus-like particles are supra-molecular assemblages, usually icosahedral or rod-like structures. They incorporate key immunologic features of viruses which include repetitive surfaces, particulate structures and induction of innate immunity through activation of pathogen-associated molecular-pattern recognition receptors. They carry no replicative genetic information and can be produced recombinantly in large scale. Virus-like particles thus represent a safe and effective vaccine platform for inducing potent B- and T-cell responses. In addition to being effective vaccines against the corresponding virus from which they are derived, virus-like particles can also be used to present foreign epitopes to the immune system. This can be achieved by genetic fusion or chemical conjugation. This technological innovation has greatly broadened the scope of their use, from immunizing against microbial pathogens to immunotherapy for chronic diseases. Towards this end, virus-like particles have been used to induce autoantibodies to disease-associated self-molecules involved in chronic diseases, such as hypertension and Alzheimer's disease. The recognition of the potent immunogenicity and commercial potential for virus-like particles has greatly accelerated research and development activities. During the last decade, two prophylactic virus-like particle vaccines have been registered for human use, while another 12 vaccines entered clinical development.
Authors:
Gary T Jennings; Martin F Bachmann
Related Documents :
8854018 - Potential of chimaeric plant virus particles as novel, stable vaccines.
9126268 - Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficie...
18635088 - Viral infection of the symbiotic chlorella-like alga present in hydra viridis.
8008188 - Delivery of virus-sized iron oxide particles to rodent cns neurons.
8083518 - Methods for studying antiviral functions of macrophages and mononuclear phagocytes.
11967288 - Human immunodeficiency virus type 1 uses lipid raft-colocalized cd4 and chemokine recep...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Biological chemistry     Volume:  389     ISSN:  1431-6730     ISO Abbreviation:  Biol. Chem.     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-10-27     Completed Date:  2008-11-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9700112     Medline TA:  Biol Chem     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  521-36     Citation Subset:  IM    
Affiliation:
Cytos Biotechnology AG, CH-8952 Zurich-Schlieren, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / immunology,  prevention & control
Animals
B-Lymphocytes / immunology
Epitopes, B-Lymphocyte / genetics,  immunology
Humans
Hypertension / immunology,  prevention & control
T-Lymphocytes / immunology
Tobacco Use Disorder / immunology,  prevention & control
Viral Vaccines / chemistry,  immunology*
Virion / chemistry,  immunology*
Chemical
Reg. No./Substance:
0/Epitopes, B-Lymphocyte; 0/Viral Vaccines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Lipopolysaccharide: a tool and target in enterobacterial vaccine development.
Next Document:  Maintenance of serological memory.